## Abstract Availability of human chondrocytes is a major limiting factor regarding drug discovery projects and tissue replacement therapies. As an alternative human mesenchymal stem cells (hMSCs) from bone marrow are taken into consideration as they can differentiate along the chondrogenic lineage
Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels
✍ Scribed by Ulrich Nöth; Lars Rackwitz; Andrea Heymer; Meike Weber; Bernd Baumann; Andre Steinert; Norbert Schütze; Franz Jakob; Jochen Eulert
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 460 KB
- Volume
- 83A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The chondrogenic differentiation of bone marrow‐derived human mesenchymal stem cells (MSCs) in a collagen type I hydrogel, which is in clinical use for matrix‐based autologous chondrocyte transplantation (ACT), was investigated. Collagen hydrogels with 2.5 × 10^5^ MSCs/mL were fabricated and cultured for 3 weeks in a serum‐free, defined, chondrogenic differentiation medium containing 10 ng/mL TGF‐β1 or 100 ng/mL BMP‐2. Histochemistry revealed morphologically distinct, chondrocyte‐like cells, surrounded by a sulfated proteoglycan‐rich extracellular matrix in the TGF‐β1 and BMP‐2 treated group, with more elongated cells seen in the BMP‐2 treated group. Immunohistochemistry detected collagen type II (Col II) in the TGF‐β1 and BMP‐2 treated group. Collagen type X (Col X) staining was positive in the TGF‐β1 but only very weak in the BMP‐2 treated group. RT‐PCR analyses revealed a specific chondrogenic differentiation with the expression of the cartilage specific marker genes Col II, Col X, and aggrecan (AGN) in the TGF‐β1 and the BMP‐2 treated group, with earlier expression of these marker genes in the TGF‐β1 treated group. Interestingly, MSC‐gels cultured in DMEM with 10% FBS (control) indicated few isolated chondrocyte‐like cells but no expression of Col II or Col X could be detected. The results show, that MSCs cultured in a collagen type I hydrogel are able to undergo a distinct chondrogenic differentiation pathway, similar to that described for MSCs cultured in high‐density pellet cultures. These findings are valuable in terms of ex vivo predifferentiation or in situ differentiation of MSCs in collagen hydrogels for articular cartilage repair. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res 2007
📜 SIMILAR VOLUMES
## Abstract Much research has focused on the differentiation of human mesenchymal stem cells (hMSCs) in monolayer culture; however, little is known about their differentiation potential in three‐dimensional culture conditions. In this research, hMSCs were encapsulated in a photocrosslinkable, injec
This study examined whether mesenchymal stem cells (MSCs), which are stem cells originated from embryonic mesoderm, are able to differentiate into functional hepatocyte-like cells in vitro. MSCs were isolated from human bone marrow and umbilical cord blood, and the surface phenotype and the mesoderm
## Abstract Spaceflight leads to reduced bone mineral density in weight bearing bones that is primarily attributed to a reduction in bone formation. We have previously demonstrated severely reduced osteoblastogenesis of human mesenchymal stem cells (hMSC) following 7 days culture in modeled microgr
Electromagnetic fields (EMF) have been shown to exert beneficial effects on cartilage tissue. Nowadays, differentiated human mesenchymal stem cells (hMSCs) are discussed as an alternative approach for cartilage repair. Therefore, the aim of this study was to examine the impact of EMF on hMSCs during